NSEOutcome of Board Meeting14 Jul 2026 · 14 Jul 2026, 12:40 pm
Outcome of Board Meeting
Dhampur Bio Organics Limited · DBOL
✦ AI SummaryResults
Dhampur Bio Organics Limited has submitted its financial results for the quarter ended June 30, 2026, and the Board of Directors has approved the unaudited standalone and consolidated financial results. The Board has also decided not to declare an interim dividend and has appointed an Internal Auditor for the financial year 2026-27.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Dhampur Bio Organics Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
Attachments (1)
📄pdf
Download →
DBOLTD_14072026123558_Outcome_BM14072026_DBOtoSE.pdf
View document text
Dhampur Bio Organics Ltd.
Date: July 14, 2026
The Manager - Listing The Manager - Listing
Dept of Corp. Services, National Stock Exchange of India Ltd.
BSE Limited Exchange plaza,Bandra Kurla Complex
P.J. Towers, Dalal Street, Fort, Bandra East
Mumbai - 400 001 Mumbai - 400 051
Scrip Code: 543593 Symbol: DBOL
Dear Sir/Mam,
Sub: Outcome of Board Meeting held on July 14, 2026
Pursuant to the provisions of the Regulations 30 and Regulation 33 of SEBI (Listing
Obligations and Disclosure Requirements) Regulations 2015 (herein after referred to
as "Listing Regulation"), we wish to inform you that, the Board of Directors at its
Meeting held today i.e. Tuesday, July 14, 2026, has inter-alia considered the
following:
i) Approved Unaudited Standalone and Consolidated Financial Results for the
quarter ended June 30, 2026.
ii) The Board considered and decided not to declare interim dividend.
iii) Approved appointment of Internal Auditor for the financial year 2026-27
We are enclosing herewith:
a) The Unaudited (Standalone & Consolidated) Financial Results of the Company
for quarter ended on June 30, 2026 along with Limited Review Report on the
Standalone and Consolidated Financial Results of the Company for quarter
ended on June 30, 2026 as Annexure A;
b) The details as required under Regulation 30 of the Listing Regulations read with
Master Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January
30, 2026 is attached as Annexure B for appointment of Internal Auditor for
financial year 2026-27.
The same are also being uploaded on the website of the Company i.e.
http://www.dhampur.com. The Unaudited Financial Results shall be published in
newspapers as per the Listing Regulations.
Corp. Office: Second Floor, Plot No. 201, Okhla Industrial Estate, Phase 111, New Delhi -110 020, India, Tel: +91-11 - 6905 S200, Email: corporateoffice@dhampur.com, Website: www.dhampur.com
Regd. Office: Sugar Mill Compound, Village & Post - Asmoli, Dist!. Sambhal, Uttar Pradesh - 244304, Tel: +91-7302318313
CIN. L15100UP2020PLC136939
Dhampur Bio Organics Ltd.
The meeting of the Board of Directors of the Company commenced at 11:40 AM (1ST)
and concluded at 12:25 PM (1ST).
You are requested to take the above information on record.
Your Sincerely,
For Dhampur Bio Organics Limited
Ashu Rawat
Company Secretary & Compliance Office
Corp. Office: Second Floor, Plot No. 201, Okhla Industrial Estate, Phase 111, New Delhi -110 020, India, Tel: +91-11 - 6905 S200, Email: corporateoffice@dhampur.com, Website: www.dhampur.com
Regd. Office: Sugar Mill Compound, Village & Post - Asmoli, Dist!. Sambhal, Uttar Pradesh - 244304, Tel: +91-7302318313
CIN. L15100UP2020PLC136939
Annexure A
Mittal Gupta & Co.
~ Chartered Accountants
IND IA
10/437, Khalasi Lines, Kanpur -208001
Tel: 0512-3158490 E-mail: mgco@mgcoca.in
Independent Auditor's Limited Review Report on Unaudited Standalone Financial
Results of Dhampur Bio Organics Limited for the quarter ended June 30, 2026,
pursuant to the Regulation 33 of the SEBI (Listing Obligation and Disclosure
Requirements) Regulations, 2015.
The Board of Directors of
Dhampur Bio Organics Limited
1. We have reviewed the accompanying statement of Unaudited Standalone Financial
Results of Dhampur Bio Organics Limited ('the Company') for the quarter ended June 30,
2026 (hereinafter referred to as "Statement"), being submitted by the company pursuant to
the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015, as amended to date ("Listing Regulation").
2. This statement, which is the responsibility of the Company's Management and approved
by the Company's Board of Directors, has been prepared in accordance with the
recognition and measurement principles laid down in the Indian Accounting Standard 34,
(Ind AS 34) "Interim Financial Reporting" prescribed under Section 133 of the
Companies Act, 2013 as amended, read with relevant rules issued thereunder and other
accounting principles generally accepted in India. Our responsibility is to express a
conclusion on the Statement based on our review.
3. We conducted our review in accordance with the Standard on Review Engagement (SRE)
2410, "Review of Interim Financial Information performed by the Independent Auditor of
the Entity" issued by the Institute of Chartered Accountants of India. This Standard
requires that we plan and perform the review to obtain moderate assurance about whether
the Statement is free of material misstatement. A review is limited primarily to inquiries
of company personnel and an analytical procedure applied to financial data and thus
provides less assurance than an audit. We have not performed an audit and accordingly,
we do not express an audit opinion.
Mittal Gupta & Co.
Chartered Accountants
IN DIA
10/437, Khalasi Lines, Kanpur -208001
Tel: 0512-3158490 E-mail: mgco_@mgcoca.in
4. Based on our review conducted as stated in Paragraph 3 above, nothing has come to our
attention that causes us to believe that the accompanying Statement of Unaudited
Standalone Financial Results prepared in accordance with applicable accounting
standards, and other recognized accounting practices and policies has not disclosed the
information required to be disclosed in terms of Regulation 33 of Listing Regulations
including the manner in which it is to be disclosed, or that it contains any material
misstatement.
5. The Statement includes the results for the quarter ended March 31, 2026, being the
balancing figure between the audited figures for the year ended March 31, 2026 and
published unaudited figures for the nine months ended December 31, 2025.
Our conclusion on the Statement is not modified in respect of the above matters.
For MITTAL GUPTA & CO.
Chartered Accountants
FRN: 00187 4C /'.,~ Gupt,, &
,, ..., . C
tift ': , ' Y
(Bihari Lal Gupta)
Partner
M. No. 073794
Place: New Delhi
Date: 14.07.2026
1607 31~ 4-L NM~ J A 3½ 89
UDIN:
DHAMPUR BIO ORGANICS LIMITED
Regd. Office: Sugar Mill Compound, Village Asmoli Sambhal Moradabad, UP- 244304 IN
CIN - L15100UP2020PLC136939, Phone No - +91-7302318313
Email: investors@dhamour.com, Website - www.dhamour.com
Statement of Unaudited Standalone Financial Results for the Quarter ended June 30, 2026
(till Crore)
Quarter Ended Year Ended
SI.No. Particulars 30-Jun-26 31-Mar-26 30-Jun-25 31-Mar-26
(Unaudited) (Audited)• (Unaudited) (Audited)
Continuing OJ;?:erations
1. Income from operations
(a) Revenue from operations 939.55 706.19 788.15 2,953.93
(b) Other income 0.95 6.75 1.62 30.22
Total Income from operations (a + b) 940.50 712.94 789.77 2,984.15
2. Expenses
(a) Cost of Raw Materials Consumed 65.49 761.95 138.92 1,431.00
{b) Excise duty on sale of goods 385.67 233.89 .258.16 1,024.16
(c) Purchases of stock-in-trade 88.62 0.91 18.20 39.44
(d) Changes in inventories of finished goods, work-in -progress and stock-in-trade 296.94 (470.12) 289.66 (1.46)
(e) Employees benefits expenses 23.50 26.69 20.16 93.29
(f) Depreciation and amortisation expenses 12.87 12.57 12.18 50.38
(g) Finance costs 15.56 13.99 18.88 54.41
(h) Other expenses 68.00 72.47 51.11 242.49
Total expenses (a to h) 956.65 652.35 807.27 2,933.71
3. Profit/ (Loss) before exceptional items and tax from continuing operations (16.15) 60.59 {17.50) 50.44
(1-2)
4. Exceptional Items -
5. Profit/ (Loss) after exceptional items and before tax from continuing (16.15) 60.59 (17.50) 50.44
operations (3-4)
6. Tax expenses
(a) Current tax 5.95 6.43
(b) Deferred tax (4.01) 16.50 (6.04) 12.75
Total Tax Expenses (a + b) (4.01) 22.45 (6.04) 19.18
7. Profit/ (Loss) for the period (5-6) from continuing operations (A) (12.14\ 38.14 111.46) 31.26
Discontinued Operations (Refer note (vi)
Profit/(Loss) for the period from discontinued operations (1.71) 10.73 (12.08) (10.15)
Gain on sale of undertaking 63.89 -
Profit/ (Loss) from discontinued operations before taxes 62.18 10.73 (12.08) (10.15)
Less: Tax expense/(income) of discontinued operations 11.64 2.87 14.17) (3.86)
Profit/ (
[Showing first 8,000 characters — download PDF for full document]